Drug intelligence / Profile preview

Mukkamukkutu Gulika

Development stage: Preclinical
Lead developer: Arya Vaidya Sala Kottakkal
Administration: Oral

Overview

Mukkamukkutu Gulika is a traditional polyherbal Ayurvedic tablet manufactured by Kottakkal Arya Vaidya Sala. It is indicated for the treatment of various types of fevers, including those caused by infections, and is used for immune enhancement. The formulation is a combination of several medicinal herbs known in Ayurveda for their antipyretic (Jwarahara) and immunomodulatory properties. During the COVID-19 pandemic, it was utilized as a supportive treatment to manage symptoms and boost host immunity. As a traditional medicine, its efficacy is based on historical use and observational studies rather than standard Phase 1/2/3 clinical trials.

Brand names: Mukkamukkutu Gulika
Other names: Mukkamukkutu VatiMukkamukkuduvathiMukkamukkudu Vathi

Beyond the preview

Go deeper on Mukkamukkutu Gulika.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mukkamukkutu Gulika.

Explore the full profile